← Back to Search

Home Visits for Pediatric HIV Adherence

N/A
Waitlist Available
Led By Elizabeth McFarland
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Taking at least 1 antiretroviral medication
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will test whether home visits to HIV infected children and youth, which identify previously unrecognized adherence barriers and provide support and education, will increase medication adherence and improve patient satisfaction.

Who is the study for?
This trial is for English-speaking children and youth with HIV who live in the Denver metro area and are on at least one antiretroviral medication. It aims to help those struggling with sticking to their medication schedule.Check my eligibility
What is being tested?
The study tests if home visits can uncover hidden barriers to taking HIV meds regularly, provide support, and improve relationships between patients and healthcare providers. Adherence will be measured before/after visits using questionnaires and pill counts or monitoring systems.See study design
What are the potential side effects?
Since this trial focuses on home visits rather than a new drug, there aren't direct side effects like you'd expect from medication. However, participants may experience increased stress or privacy concerns due to having health workers visit their homes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below
Select...
I am currently taking medication for HIV.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled
Elizabeth McFarlandPrincipal Investigator

Media Library

Home Visits Clinical Trial Eligibility Overview. Trial Name: NCT00006439 β€” N/A
Human Immunodeficiency Virus Infection Research Study Groups:
Human Immunodeficiency Virus Infection Clinical Trial 2023: Home Visits Highlights & Side Effects. Trial Name: NCT00006439 β€” N/A
Home Visits 2023 Treatment Timeline for Medical Study. Trial Name: NCT00006439 β€” N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the selection criteria for this research include adults, aged 20 and older?

"This trial is actively seeking individuals aged between infancy and 24 years old."

Answered by AI
~233 spots leftby Mar 2025